1-1 of 1
Alessadra Ferrajoli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating CD52 and CD20 Levels Predict for Progression and Survival in Patients with CLL Treated with Fludarabine (F), Cyclophosphamide (C), and Rituximab (FCR).

Gheath Alatrash, DO, PhD, Michael J. Keating, MBBS, Susan O’Brien, MD, Xuemei Wang, MS, Taghi Manshouri, MS,BS, Stefan Faderl, MD, Alessadra Ferrajoli, MD, Hagop M. Kantarjian, MD, Susan Lerner, MS,BA, William G. Wierda, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2330.
https://doi.org/10.1182/blood.V108.11.2330.2330
Published: 2006